Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 30 June 2023

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 57 Renminbi (CNY) 17 Euro (EUR) 11 Swiss franc (CHF) 8 Indian rupee (INR) 4 Other currencies (CAD, DKK, GBP, HDK, SEK) 3 #672a66 #49753d #21659a #eabc00 #60504c #03375e #6fa231 #d997b6 #cc5d3f #B7D4D8
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Private companies 35 Public (from private) companies 26 Public companies 18 Cash and cash equivalents 11 Funds 9 Other assets 1 #672a66 #49753d #21659a #eabc00 #60504c #03375e #6fa231 #d997b6 #cc5d3f #B7D4D8
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Profitable 41 Products on the market 24 Preclinical 7 Phase I 7 Phase II 15 Phase III 6 #672a66 #49753d #21659a #eabc00 #60504c #03375e #6fa231 #d997b6 #cc5d3f #B7D4D8
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 25 Synthetic biology 19 Oncology 15 Digital Health 10 Central nervous system 10 Immunology/Inflammation 8 Orphan diseases 7 Medical technology / diagnostics 6 #672a66 #49753d #21659a #eabc00 #60504c #03375e #6fa231 #d997b6 #cc5d3f #B7D4D8